193 related articles for article (PubMed ID: 11719685)
1. First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients.
Bjerner T; Johansson L; Ericsson A; Wikström G; Hemmingsson A; Ahlström H
Radiology; 2001 Dec; 221(3):822-6. PubMed ID: 11719685
[TBL] [Abstract][Full Text] [Related]
2. First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection.
Panting JR; Taylor AM; Gatehouse PD; Keegan J; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
J Magn Reson Imaging; 1999 Sep; 10(3):404-10. PubMed ID: 10508302
[TBL] [Abstract][Full Text] [Related]
3. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography.
Taylor AM; Panting JR; Keegan J; Gatehouse PD; Amin D; Jhooti P; Yang GZ; McGill S; Burman ED; Francis JM; Firmin DN; Pennell DJ
J Magn Reson Imaging; 1999 Feb; 9(2):220-7. PubMed ID: 10077017
[TBL] [Abstract][Full Text] [Related]
4. High in-plane resolution T2-weighted magnetic resonance imaging of acute myocardial ischemia in pigs using the intravascular contrast agent NC100150 injection.
Bjerner T; Wikström G; Johansson L; Ahlström H
Invest Radiol; 2004 Aug; 39(8):470-8. PubMed ID: 15257208
[TBL] [Abstract][Full Text] [Related]
5. Improvement of image quality of non-invasive coronary artery imaging with magnetic resonance by the use of the intravascular contrast agent Clariscan (NC100150 injection) in patients with coronary artery disease.
Klein C; Schalla S; Schnackenburg B; Bornstedt A; Hoffmann V; Fleck E; Nagel E
J Magn Reson Imaging; 2003 Jun; 17(6):656-62. PubMed ID: 12766894
[TBL] [Abstract][Full Text] [Related]
6. Myocardial perfusion and MR angiography of chest with SH U 555 C: results of placebo-controlled clinical phase i study.
Reimer P; Bremer C; Allkemper T; Engelhardt M; Mahler M; Ebert W; Tombach B
Radiology; 2004 May; 231(2):474-81. PubMed ID: 15044749
[TBL] [Abstract][Full Text] [Related]
7. Use of the intravascular contrast agent NC100150 injection in spin-echo and gradient-echo imaging of the heart.
Taylor AM; Panting JR; Keegan J; Gatehouse PD; Jhooti P; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
J Cardiovasc Magn Reson; 1999; 1(1):23-32. PubMed ID: 11550338
[TBL] [Abstract][Full Text] [Related]
8. MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
Wacker FK; Reither K; Ebert W; Wendt M; Lewin JS; Wolf KJ
Radiology; 2003 Feb; 226(2):459-64. PubMed ID: 12563140
[TBL] [Abstract][Full Text] [Related]
9. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
[TBL] [Abstract][Full Text] [Related]
10. Initial experience with the intravascular contrast agent NC100150-injection (Clariscan) for breath-hold and navigator-gated magnetic resonance coronary artery imaging.
Bunce NH; Keegan J; Gatehouse PD; Moon JC; Firmin DN; Hoffmann V; Pennell DJ
J Magn Reson Imaging; 2002 Aug; 16(2):217-23. PubMed ID: 12203771
[TBL] [Abstract][Full Text] [Related]
11. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
[TBL] [Abstract][Full Text] [Related]
12. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
13. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
[TBL] [Abstract][Full Text] [Related]
14. Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.
Wacker FK; Wendt M; Ebert W; Hillenbrandt C; Wolf KJ; Lewin JS
Acad Radiol; 2002 Nov; 9(11):1251-4. PubMed ID: 12449357
[TBL] [Abstract][Full Text] [Related]
15. Breath-hold coronary MR angiography with volume-targeted imaging.
Wielopolski PA; van Geuns RJ; de Feyter PJ; Oudkerk M
Radiology; 1998 Oct; 209(1):209-19. PubMed ID: 9769834
[TBL] [Abstract][Full Text] [Related]
16. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.
Harisinghani MG; Saini S; Weissleder R; Hahn PF; Yantiss RK; Tempany C; Wood BJ; Mueller PR
AJR Am J Roentgenol; 1999 May; 172(5):1347-51. PubMed ID: 10227514
[TBL] [Abstract][Full Text] [Related]
17. Breath-hold 3D MR coronary angiography with a new intravascular contrast agent (feruglose)--first clinical experiences.
Sandstede JJ; Pabst T; Wacker C; Wiesmann F; Hoffmann V; Beer M; Kenn W; Bauer W; Hahn D
Magn Reson Imaging; 2001 Feb; 19(2):201-5. PubMed ID: 11358658
[TBL] [Abstract][Full Text] [Related]
18. Perfusion MR imaging with a superparamagnetic iron oxide using T2-weighted and susceptibility-sensitive echoplanar sequences: evaluation of tumor vascularity in hepatocellular carcinoma.
Ichikawa T; Arbab AS; Araki T; Touyama K; Haradome H; Hachiya J; Yamaguchi M; Kumagai H; Aoki S
AJR Am J Roentgenol; 1999 Jul; 173(1):207-13. PubMed ID: 10397128
[TBL] [Abstract][Full Text] [Related]
19. High-resolution magnetic resonance coronary angiography of the entire heart using a new blood-pool agent, NC100150 injection: comparison with invasive x-ray angiography in pigs.
Johansson LO; Nolan MM; Taniuchi M; Fischer SE; Wickline SA; Lorenz CH
J Cardiovasc Magn Reson; 1999; 1(2):139-43. PubMed ID: 11550346
[TBL] [Abstract][Full Text] [Related]
20. Quantification of renal perfusion abnormalities using an intravascular contrast agent (part 2): results in animals and humans with renal artery stenosis.
Schoenberg SO; Aumann S; Just A; Bock M; Knopp MV; Johansson LO; Ahlstrom H
Magn Reson Med; 2003 Feb; 49(2):288-98. PubMed ID: 12541249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
